Status:
RECRUITING
Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19
Lead Sponsor:
Université du Québec à Trois-Rivières
Conditions:
Hyposmia
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT)....
Detailed Description
Patients who meet the criteria, who have agreed to participate in this research project and sign the consent form will be placed in one of the following two groups: ● Experimental group (olfactory tr...
Eligibility Criteria
Inclusion
- Patient diagnosed positive for COVID-19 with persistent olfactory dysfunction
- Willing and able to provide written informed consent
- Understand and read the French language
- Have an internet connection and a working email address
Exclusion
- Anosmia and hyposmia pre-covid-19
- Be known chronic rhinosinusitis with or without nasal polyposis
- Have received radiotherapy or chemotherapy for Head and Neck Tumors
- Have a diagnosis of Alzheimer's, Parkinson's, multiple sclerosis or any other neurodegenerative disease 5. Have a brain tumor or ENT diagnosis 6. History of naso-sinus surgery; 7. History of traumatic brain injury
Key Trial Info
Start Date :
May 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05384561
Start Date
May 31 2022
End Date
September 1 2025
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Université du Québec à Trois-Rivières
Trois-Rivières, Quebec, Canada, G8Z 4M3